NYtor, partner in smart molecular diagnostic assay development!
NYtor designs and develops smart molecular detection assays for a broad range of applications, in collaboration with different partners. Our strength lies in the development of qPCR and point-of-care assays with main focus on the detection of pathogens and their antibiotic resistance and on early cancer screening.
Company Details
- Employees
- 8
- Founded
- 2007
- Address
- Berg En Dalseweg 199, Nijmegen,6522 Bj,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nytor.nl
- Keywords
- quantitative PCR (qPCR), multiplex assay design, molecular beacons, contract-development, Point-of-Care, antibiotic resistance, Isothermal amplification, Lab on a chip, digital PCR, Next Generation Sequencing, assay development, molecular diagnostics, companion diagnostics, rapid diagnostics, home tests, veterinary diagnostics, human diagnostics, water management, plant diagnostics, infectious diseases, oncology, sexually transmitted diseases, theranostics, LAMP, assay validation, SuperSelective primers.
- HQ
- Nijmegen
Nytor Questions
Nytor's website is nytor.nl
Nytor's LinkedIn profile is https://nl.linkedin.com/company/nytor
Nytor has
8 employees.
View email and phone details for 8
employees at Nytor.
Nytor's industry is
Biotechnology Research
Nytor's top competitors are
Nimagen,
Magtivio B.v.,
Future Diagnostics Solutions,
Proqr Therapeutics,
Future Diagnostics,
Nbcl - Novel Biomarkers Catalyst Lab,
Bioengineering Taltech,
Xheal,
Cyclomics,
Hcm Medical.
Nytor's categories are Biotechnology Research
Nytor's founding year is 2007
